D. Miglietta

发表

NO donors exhibit anti‐inflammatory properties by modulating inflammatory signatures and by regulating the life cycle of dendritic cells

M. Foti, C. Ripamonti, Angela Papagna, 2017, Journal of leukocyte biology.

A dual acting compound releasing nitric oxide (NO) and ibuprofen, NCX 320, shows significant therapeutic effects in a mouse model of muscular dystrophy

E. Clementi, D. Cattaneo, S. Brunelli, 2011, Pharmacological research.

Neutrophil elastase in bronchiectasis

F. Blasi, P. Tarsia, G. Sotgiu, 2017, Respiratory Research.

Nitric oxide prevents atorvastatin‐induced skeletal muscle dysfunction and alterations in mice

E. Ongini, A. Monopoli, G. D’Antona, 2013, Muscle & nerve.

Naproxcinod shows significant advantages over naproxen in the mdx model of Duchenne Muscular Dystrophy

E. Clementi, E. Ongini, B. Vergani, 2015, Orphanet Journal of Rare Diseases.

Characterization of the anti-inflammatory properties of NCX 429, a dual-acting compound releasing nitric oxide and naproxen.

M. Perretti, C. Bardelli, J. Dalli, 2015, Life sciences.

Nitric oxide enhances the anti-inflammatory and anti-atherogenic activity of atorvastatin in a mouse model of accelerated atherosclerosis.

E. Ongini, A. Monopoli, P. Gresele, 2012, Cardiovascular research.

Synthesis of novel nitric oxide (NO)-releasing esters of timolol.

F. Nicoli, D. Ronchetti, M. Batugo, 2009, Bioorganic & medicinal chemistry letters.

Evaluation of active neutrophil elastase in sputum of bronchiectasis and cystic fibrosis patients: A comparison among different techniques.

F. Blasi, G. Sotgiu, J. Chalmers, 2019, Pulmonary pharmacology & therapeutics.

Discovery of Clinical Candidate CHF-6366: A Novel Super-soft Dual Pharmacology Muscarinic Antagonist and β2 Agonist (MABA) for the Inhaled Treatment of Respiratory Diseases.

S. Catinella, L. Venturi, P. Puccini, 2022, Journal of medicinal chemistry.

CHF6366: characterisation of the bronchoprotective effect of a novel MABA compound in the experimental bronchospasm model in anaesthetised guinea pigs

B. Riccardi, G. Villetti, A. Murgo, 2017 .

Long-term treatment with naproxcinod significantly improves skeletal and cardiac disease phenotype in the mdx mouse model of dystrophy.

E. Ongini, K. Uaesoontrachoon, K. Nagaraju, 2014, Human molecular genetics.

NAPROXCINOD COUNTERBALANCES VASOCONSTRICTION DUE TO COX INHIBITION IN HUMAN ARTERIES WITH ENDOTHELIAL DYSFUNCTION: PP.6.253

B. Vergani, J. Padron, A. Poggi, 2010 .

Nitric Oxide-Donating Atorvastatin Attenuates Neutrophil Recruitment During Vascular Inflammation Independent of Changes in Plasma Cholesterol

E. Ongini, A. Corsini, S. Bellosta, 2013, Cardiovascular Drugs and Therapy.

Nitric oxide-donating carbonic anhydrase inhibitors for the treatment of open-angle glaucoma.

C. Supuran, Alessandro Cecchi, F. Impagnatiello, 2009, Bioorganic & medicinal chemistry letters.

Enhanced oxygen saturation in optic nerve head of non-human primate eyes following the intravitreal injection of NCX 434, an innovative nitric oxide-donating glucocorticoid.

E. Ongini, B. Khoobehi, F. Impagnatiello, 2011, Journal of ocular pharmacology and therapeutics : the official journal of the Association for Ocular Pharmacology and Therapeutics.

Nitric oxide-donating carbonic anhydrase inhibitors for the treatment of open-angle glaucoma.

C. Supuran, Alessandro Cecchi, F. Impagnatiello, 2009, Bioorganic & medicinal chemistry letters.